title: ["In-situ split" (ISS) liver resection: new aspects of technique and indication].
abstract: The combination of right portal vein ligation with complete parenchyma dissection ("in-situ split", ISS) for rapid hypertrophy induction of the left-lateral liver lobe is a novel strategy to convert primarily irresectable liver tumours into a resectable stage. Available data so far show a 60-80 % growth induction of the remnant liver within 7(- 9) days. Certainly, a novel concept that comprises two operations within a very short time period raises questions. Based on the very few literature reports that have been published so far, as well as our own experience, we here discuss technical issues such as the use of a plastic sheet on the resection margin, the possibility of laparoscopic dissection and the timing of the second operation. Moreover, aspects of the preoperative diagnostic work-up that is necessary are assessed. Finally, open questions, e.g., concerning the influence of preoperative chemotherapy and the use of ISS in patients with cirrhosis are evaluated. In summary, the assessment of chances and risks of this novel concept with regard to indication and technical issues helps to provide the potentially curative option of the "in-situ split" procedure to more patients with marginal or even irresectable liver tumours.
authors.affiliation: Klinik und Poliklinik für Chirurgie, Universitätsklinikum Regensburg, Deutschland.
authors.forename: S A
authors.initials: SA
authors.lastname: Lang
authors.affiliation: Klinik und Poliklinik für Chirurgie, Universitätsklinikum Regensburg, Deutschland.
authors.forename: M
authors.initials: M
authors.lastname: Loss
authors.affiliation: Klinik und Poliklinik für Chirurgie, Universitätsklinikum Regensburg, Deutschland.
authors.forename: H J
authors.initials: HJ
authors.lastname: Schlitt
mesh_terms: D006498:Hepatectomy / Q000379:methods*; D006801:Humans; D006984:Hypertrophy; D010535:Laparoscopy / Q000379:methods; D008026:Ligation; D008099:Liver / Q000473:pathology; D008103:Liver Cirrhosis / Q000473:pathology / Q000601:surgery; D008113:Liver Neoplasms / Q000473:pathology / Q000601:surgery*; D008115:Liver Regeneration / Q000502:physiology*; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D011169:Portal Vein / Q000601:surgery*; D011183:Postoperative Complications / Q000503:physiopathology; D011379:Prognosis